GlaxoSmithKline (GSK) discontinued Alli in the US in 2013. This wasn’t a sudden decision; sales had been declining for several years.
Reasons for Discontinuation
- Decreasing sales: Profitability became unsustainable. Market competition: Other weight-loss products gained traction. Marketing challenges: Effectively communicating the product’s benefits proved difficult.
While Alli is unavailable in the US, it remains accessible in other countries under different names or formulations. Importantly, check local regulations and consult a doctor before using any weight-loss medication.
Alternatives to Alli
Prescription weight-loss medications: Your doctor can assess your needs and prescribe a suitable option. Lifestyle changes: A balanced diet and regular exercise are crucial for sustainable weight management. Over-the-counter options: Explore other weight-loss aids available in your region.
Remember, consulting a healthcare professional is vital before starting any weight-loss program, particularly if you have underlying health conditions.
Current Status
Currently, there are no confirmed plans for Alli’s return to the US market. GSK has not publicly announced intentions to reintroduce it.
